Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06659744 · ClinicalTrials.gov registry record
Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims
A clinical trial of Diabetes Mellitus, Type 2, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- 158,310
- Enrollment target
- 1
- Study location
NCT06659744 is a study of Diabetes Mellitus, Type 2 that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 158,310 participants, above the 4,030-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (3828% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06659744, a study of Diabetes Mellitus, Type 2, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- 158,310 participants
- Enrollment target
- 1
- Study location
Study Summary
Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such studies.
Conditions Studied
Interventions
- DRUG New use of semaglutide injection
- DRUG New initiation of sitagliptin
Study Locations (1)
Massachusetts
- Brigham and Women's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158,310 participants |
| Start Date | 2024-10-24 |
| Est. Completion | 2025-03-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06659744
The ClinicalTrials.gov registry entry for NCT06659744 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 158,310 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 4,030-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (3828% higher). The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which New use of semaglutide injection is the first listed.
NCT06659744 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06659744 about?
NCT06659744 is a clinical study titled "Emulation of the SUSTAIN6 Diabetes Trial Using Healthcare Claims". Investigators are building an empirical evidence base for real world data through large-scale emulation of randomized controlled trials. The investigators' goal is to understand for what types of clinical questions real world data analyses can be conducted with confidence and how to implement such s...
What is the current status of trial NCT06659744?
This trial is currently completed. The enrollment target is 158,310 participants. The study started on 2024-10-24. Estimated completion is 2025-03-06.
What conditions does trial NCT06659744 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT06659744?
The interventions under investigation include: New use of semaglutide injection (DRUG), New initiation of sitagliptin (DRUG).
Who is sponsoring clinical trial NCT06659744?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06659744 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Drug Interaction Potential of Pro-Inflammatory Conditions
RECRUITING
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
RECRUITING · Phase 1
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.